A Clostridium hathewayi isolate in blood culture of a patient with an acute appendicitis

Anaerobe

Volumn 35, Issue , 2015, Pages 44-47

  Randazzo, Adrien ^a   Kornreich, Anne ^a   Lissoir, Bénédicte ^a  

^a Medical Laboratory Grand Hôpital de Charleroi   (Belgium)

Author keywords

Bacteremia; Blood culture; Clostridium hathewayi; Hungatella hathewayi

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BILIRUBIN; C REACTIVE PROTEIN; CEFUROXIME; CLINDAMYCIN; HEMOGLOBIN; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL PAIN; ACUTE APPENDICITIS; ADULT; ANTIBIOTIC SENSITIVITY; APPENDECTOMY; ASIAN; BACTERIUM ISOLATE; BILIRUBIN BLOOD LEVEL; BLOOD CULTURE; CASE REPORT; CLOSTRIDIUM; CLOSTRIDIUM HATHEWAYI; COMPUTER ASSISTED TOMODENSITOMETRY; COMPUTER ASSISTED TOMOGRAPHY; HEMATOLOGY; HUMAN; LAPAROSCOPIC APPENDECTOMY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; VITAL SIGN; APPENDICITIS; ASIAN CONTINENTAL ANCESTRY GROUP; BACTEREMIA; BLOOD; CLOSTRIDIALES; COMPLICATION; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM HATHEWAYI; NEGIBACTERIA;

APPENDICITIS; ASIAN CONTINENTAL ANCESTRY GROUP; BACTEREMIA; BLOOD; CLOSTRIDIALES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84937675960     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.07.003     Document Type: Review

References (25)

1. Steer T., Collins M.D., Gibson G.R., Hippe H., Lawson P.A. Clostridium hathewayi sp. nov., from human faeces. Syst. Appl. Microbiol. 2001, 24:353-357.
2. Allen S.D., Emery C.L., Lyerly D.M. Clostridium. Manual of Clinical Microbiology 2003, 835-856. ASM Press, Washington. eighth ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
3. Jousimies-Somer H.R., Summanen P., Citron D.M., Baron E.J., Wexler H.M., Finegold S.M. Wadsworth-KTL Anaerobic Bacteriology Manual 2002, Star Publishing Company, Belmont (CA). sixth ed.
4. Ramlachana N., Andersona R.C., Andrewsa K., Labanb G., Nisbet D.J. Characterization of an antibiotic resistant Clostridium hathewayi strain from a continuous-flow exclusion chemostat culture derived from the cecal contents of a feral pig. Anaerobe 2007, 13:153-160.
5. Relman D.A., Loutit J.S., Schmidt T.M., Falkow S., Tompkins L.S. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N.Engl. J. Med. 1990, 323:1573-1580.
6. Relman D.A., Schmidt T.M., MacDermott R.P., Falkow S. Identification of the uncultured bacillus of Whipple's disease. N.Engl. J. Med. 1992, 327:293-301.
7. Breitenstein A., Wiegel J., Haertig C., Weiss N., Andreesen J.R., Lechner U. Reclassification of Clostridium hydroxybenzoicum as Sedimentibacter hydroxybenzoicus gen. nov., comb. nov., and description of Sedimentibacter saalensis sp. nov. Int. J. Syst. Evol. Microbiol. 2002, 52:801-807.
8. Collins M.D., Lawson P.A., Willems A., Cordoba J.J., Fernandez-Garayzabal J., Garcia P., Cai J., Hippe H., Farrow J.A. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 1994, 44:812-826.
9. Spring S., Merkhoffer B., Weiss N., Kroppenstedt R.M., Hippe H., Stackebrandt E. Characterization of novel psychrophilic clostridia from an Antarctic microbial mat: description of Clostridium frigoris sp. nov., Clostridium lacusfryxellense sp. nov., Clostridium bowmanii sp. nov. and Clostridium psychrophilum sp. nov. And reclassification of Clostridium laramiense as Clostridium estertheticum subsp. laramiense subsp. nov. Int. J. Syst. Evol. Microbiol. 2003, 53:1019-1029.
10. Stackebrandt E., Kramer I., Swiderski J., Hippe H. Phylogenetic basis for a taxonomic dissection of the genus Clostridium. FEMS Immunol. Med. Microbiol. 1999, 24:253-258.
11. Strompl C., Tindall B.J., Lunsdorf H., Wong T.Y., Moore E.R., Hippe H. Reclassification of Clostridium quercicolum as Dendrosporobacter quercicolus gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 2000, 50:101-106.
12. Elsayed S., Zhang K. Human infection caused by Clostridium hathewayi. Emerg. Infect. Dis. 2004 Nov, 10(11):1950-1952.
13. Kaur S., Yawar M., Kumar P.A., Suresh K. Hungatella effluvii gen. nov., sp. nov., an obligately anaerobic bacterium isolated from an effluent treatment plant, and reclassification of Clostridium hathewayi as Hungatella hathewayi gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 2014 Mar, 64(pt3):710-718.
14. Finegold S.M., Song Y., Liu C., Hecht D.W., Summanen P., Könönen E., Allen S.D. Clostridium clostridioforme: a mixture of three clinically important species. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24:319-324.
15. National Center for biotechnology information [Internet]. Rockville Pike, Bethesda, MD 20894, USA; c1993-2015. [updated 2014 June 23; cited 2015 May 4]. Available from: . http://www.ncbi.nlm.nih.gov/.
16. Linscott A.J., Flamholtz R.B., Shukla D., Song Y., Liu C., Finegold S.M. Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis. Anaerobe 2005, 11:97-98.
17. Woo P.C.Y., Lau S.K.P., Woo G.K.S., Ami Fung A.M.Y., Yiu V.P.Y., Yuen K.Y. Bacteremia due to Clostridium hathewayi in a patient with acute appendicitis. J.Clin. Microbiol. 2004 Dec, 42(12):5947-5949.
18. Tena D., Losa C., Medina-Pascual M.J., Sáez-Nieto J.A. Fournier's gangrene caused by actinomyces funkei, Fusobacterium gonidiaformans and Clostridium hathewayi. Anaerobe 2014, 27:14-16.
19. Dababneh A.S., Nagpal A., Palraj B.R., Sohail M.R. Clostridium hathewayi bacteraemia and surgical site infection after uterine myomectomy. BMJ Case Rep. 2014 Mar 4, published online, Available from: http://casereports.bmj.com/content/2014/bcr-2013-009322.full.pdf+html?eaf.
20. Erikstrup L.T., Danielsen T.K.L., Hall V., Olsen K.E.P., Kristensen B., Kahlmeter G., Fuursted K., Justesen U.S. Antimicrobial susceptibility testing of Clostridium difficile using EUCASTepidemiological cut-off values and disk diffusion correlates. Clin. Microbiol. Infect. 2012, 18:266-272.
21. Huang H., Weintraub A., Fang H., Nord C.E. Antimicrobial resistance in Clostridium difficile. Int. J. Antimicrob. Agents 2009, 34:516-522.
22. Rafii F., Park M., Wynne R. Evidence for active drug efflux in fluoroquinolone resistance in Clostridium hathewayi. Chemotherapy 2005 Aug, 51(5):256-262.
23. Chean R., Kotsanas D., Francis M.J., Palombo E.A., Jadhay S.R., Awad M.M., Lyras D., Forman T.M., Jenkin G.A. Comparing the identification of Clostridium spp. by two Matrix-Assisted laser desorption Ionization-Time of flight (MALDI-TOF) mass spectrometry platforms to 16S rRNA PCR sequencing as a reference standard: a detailed analysis of age of culture and sample preparation. Anaerobe 2014, 30:85-89.
24. Croxatto A., Prod'hom G., Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol. Rev. 2012, 36:380-407.
25. Grosse-Herrenthey A., Maier T., Gessler F., Schaumann R., Böhnel H., Kostrzewa M., Krüger M. Challenging the problem of clostridial identification with matrix-assisted laser desorption and ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Anaerobe 2008, 14:242-249.